Truist Financial Reaffirms Their Hold Rating on Amedisys (AMED)
Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...
William Blair Reaffirms Their Hold Rating on Amedisys (AMED)
William Blair analyst Matt Larew maintained a Hold rating on Amedisys (AMED – Research Report) today. The company’s shares closed yesterday at ...
Yahoo Finance29d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Houston Chronicle15d
Amedisys: Q4 Earnings Snapshot
BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...
Fierce Healthcare29d
UnitedHealth Group, Amedisys plan to divest facilities in bid to close $3.3B merger
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...
ETF Daily News7d
Amedisys (NASDAQ:AMED) Earns Equal Weight Rating from Stephens
Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. Get Amedisys alerts: Amedisys (NASDAQ:AMED – Get Free Report) last announced its quarterly earnings results on ...
ETF Daily News24d
Amedisys, Inc. (NASDAQ:AMED) Receives Average Rating of “Hold” from Analysts
Shares of NASDAQ AMED opened at $92.60 on Wednesday. The company’s 50-day simple moving average is $90.11 and its 200-day simple moving average is $93.58. Amedisys has a 52-week low of $82.15 ...
WTOP News14d
Amedisys: Q4 Earnings Snapshot
BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.
Morningstar14d
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month ...
manilatimes14d
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods ...
Yahoo Finance1d
Amedisys, Inc. (AMED)
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...